Institut Pasteur Archives

News and Trends 21 Dec 2018

French Scientists Find a Weak Spot in HIV-Infected Cells

Researchers at the Institut Pasteur were able to selectively kill the cells where HIV hides from antiretroviral drugs, opening the way for a new form of HIV treatments. The reason why HIV comes back when a person stops taking antiretroviral therapy is that it remains hidden and undetected within immune T cells. In a study […]

December 21, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 8 May 2017

French Researchers Discover a Target to Prevent Zika Birth Defects

Researchers from the Institut Pasteur and the Inserm have identified a protein target that, when overexpressed, can block Zika infections. The recent Zika epidemics in the Pacific and South America has led the World Health Organization (WHO) to declare a state of global emergency. One of the biggest concerns at the moment is that the […]

May 8, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 15 Mar 2017

France Closes in on an HIV Cure by Detecting Cells with Dormant Viruses

French researchers have found a protein only expressed in HIV-infected reservoir cells, paving the way for an HIV cure that completely eliminates the virus. Researchers from the Institut de Génétique Humaine (IGH) at Montpellier University, France, have discovered a protein, CD32a, that is only present on the surface of CD4 T cells infected with dormant HIV. This […]

March 15, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 23 Feb 2017

NGS Metagenomics Test could Curb Antibiotic-Resistant Infections

PathoQuest has shown its metagenomics sequencing technology can identify more pathogens in immunocompromised patients than the standard procedures, keeping antibiotic-resistant infections at bay. PathoQuest, a spin-off from the Institut Pasteur in Paris, develops next-generation sequencing (NGS) metagenomics tests. The company just announced the publication of results from a clinical trial comparing its iDTECT Blood technology […]

February 23, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 14 Jul 2016

Institut Pasteur & Austrian Biotech also join the World Zika Vaccine Plan

Themis is a Vienna-based vaccine developer. Together with the Institut Pasteur, it is now planning to use a measles vaccine construct to develop and start Zika vaccine trials within the next 12 months. Themis has successfully extended its existing license agreement with Institut Pasteur in Paris, which grants the company a broad access to a well-established virus vaccine vector technology. The […]

July 14, 2016 - 3 minutesmins - By Dani Bancroft

News and Trends 21 Aug 2015

Researchers dismantle one of Bacteria’s most wicked weapons: The Molecular Crossbow

Researchers from the Institut Pasteur and the National Center for Scientific Research in Paris have elucidated the molecular structure of a crossbow-like weapon from bacteria’s arsenal. Ultimately, this could help to fight infectious diseases. Bacteria are in a constant battle with innumerable other microbes in their environment, so they have to bring in the big guns to […]

August 21, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 9 Jun 2015

Kurma Partners announces the launch of its third fund Kurma Diagnostics

Kurma Diagnostics (KDx), the first Venture Capital fund dedicated to financing early-stage European innovative Diagnostic projects and companies, is here to stay. The firm Kurma Partners, author of this initiative, has received the support from several European and French institutions. The fund has raised €33 Million in its first fundraising round. KDx is a venture […]

June 9, 2015 - 2 minutesmins - By Nicolas Sainte-Foie

News and Trends 25 Mar 2015

The Institut Pasteur and IntegraGen, allies to Strengthen High-Throughput Sequencing in Microbiology

IntegraGen and the Institut Pasteur signed an agreement for high-throughput sequencing in the field of Microbiology. IntegraGen will be responsible for the technical and operational implementation of high-throughput sequencing activities for use by the microbiology experts at the National Reference Center (NRC) at the Institut Pasteur. High-throughput sequencing will be the reference tool for analysis, […]

March 25, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 4 Feb 2015

And now, Moderna signs a strategic partnership with prestigious Institut Pasteur

Moderna is the Biotech company that raised the biggest VC round ever ($450M) and which signs deals almost every week. It signed a $50M deal with Merck two weeks ago, and now signs a strategic partnership with prestigious Institut Pasteur from Paris through its new Venture Valera. Moderna is developing a proprietary mRNA therapeutics platform. Instead […]

February 4, 2015 - 2 minutesmins - By Philip Hemme

Resources

Categories

The twelve hottest biotech companies in the Boston area

Biotech bankruptcies: what to expect in 2024 following a record year?

Approaches

Therapeutic areas

RNA editing set to take off: could it outperform gene editing?

Future of cancer treatment: what will therapy look like in 2034?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us